Atrophic Gastritis
Conditions
Interventions
Control group:Control group: placebo + gastric mucosal protector
Experimental group:Experimental group: tea polyphenol tablet + gastric mucosal protector
Sponsors
Beijing Friendship Hospital ,Capital Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1.Age 18-70 years old; 2.Patients with chronic atrophic gastritis confirmed by endoscopy and pathology; 3.Those who are not pregnant and do not plan to become pregnant during the trial; 4.Those who can be followed up regularly; 5.Signed informed consent.
Exclusion criteria
Exclusion criteria: 1.Patients with severe heart, liver, kidney and other organ diseases; 2.Patients with malignant tumours; 3.Combined with organic bowel disease such as inflammatory bowel disease and intestinal obstruction; 4.Patients with coeliac disease, chronic pancreatitis, portal hypertension and other digestive diseases; 5.Patients with mental illness;those who are pregnant, lactating, may not take effective contraceptive measures when pregnant, and those who are preparing to conceive; 6.Those who are allergic to tea polyphenols and/or tepredone.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The effectiveness of tea polyphenols in repairing gastric mucosal damage in patients with atrophic gastritis after 6 months of treatment.; | — |
Secondary
| Measure | Time frame |
|---|---|
| Symptom improvement;HP infection status and eradication rate;The degree and activity of mucosal inflammation;Long-term efficacy; | — |
Countries
China
Contacts
Public ContactXing Jie
Beijing Friendship Hospital ,Capital Medical University
Outcome results
None listed